机构

• 上海药物研究所 [42]
• 合肥物质科学研究院 [15]
• 自动化研究所 [12]
• 上海生物化学与细胞生... [3]
• 近代物理研究所 [3]
• 大连化学物理研究所 [2]
• 更多

采集方式

• OAI收割 [86]
• iSwitch采集 [5]

内容类型

• 期刊论文 [91]

发表日期

• 2024 [2]
• 2023 [5]
• 2022 [16]
• 2021 [13]
• 2020 [18]
• 2019 [17]
• 更多

学科主题

• Biochemist... [1]
• Gastroente... [1]
• Oncology [1]

筛选

浏览/检索结果: 共91条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma 期刊论文  OAI收割 CANCER RESEARCH, 2024, 卷号: 84, 期号: 3, 页码: 419-433 作者:  Tao, Hongru;  Jin, Chen;  Zhou, Liyuan;  Deng, Zhenzhong;  Li, Xiao   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/04/09 Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells 期刊论文  OAI收割 ADVANCED SCIENCE, 2024, 页码: 17 作者:  Pu, Congying;  Li, Yize;  Fu, Yixian;  Yan, Yiyang;  Tao, Siyao   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/02/27 AIM2 inflammasome  chemotherapy  gut microbiome  ileal epithelial cells  immune checkpoint blockade  lactobacillus  segmented filamentous bacterium   Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割 BLOOD ADVANCES, 2023, 卷号: 7 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe   |  收藏  |  浏览/下载：16/0  |  提交时间：2023/11/10 Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 9 作者:  Li, Hua-ying;  Chen, Yi-li;  Deng, Xiang-nan;  Li, Huan-huan;  Tan, Jie   |  收藏  |  浏览/下载：23/0  |  提交时间：2023/10/17 cancer immunotherapy  B7-H3  PD-L1  bispecific antibodies  VHH  antibody-dependent cell-mediated cytotoxicity (ADCC)   Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 11, 页码: 7179-7204 作者:  Dong, Qian;  Tong, Mengya;  Yu, Xiaolu;  Wang, Lei;  Ao, Jiwei   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/10/17 Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression 期刊论文  OAI收割 JOURNAL OF CLINICAL INVESTIGATION, 2023, 卷号: 133, 期号: 9, 页码: 12 作者:  Wang, Xiaobo;  Huang, Jing;  Liu, Fenglin;  Yu, Qian;  Wang, Ruina   |  收藏  |  浏览/下载：19/0  |  提交时间：2023/10/17 A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity 期刊论文  OAI收割 MOLECULAR THERAPY, 2023, 卷号: 31, 期号: 1, 页码: 66-77 作者:  Shi, Wenqiang;  Lv, Liangyin;  Liu, Nan;  Wang, Hui;  Wang, Yang   |  收藏  |  浏览/下载：22/0  |  提交时间：2023/04/10 PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety 期刊论文  OAI收割 ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 9 作者:  Zhang, Jingfang;  Li, Wenzhe;  Qi, Yafei;  Wang, Guorong;  Li, Lele   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/02/22 DNA Nanotechnology  Immunotherapy  Metal-Organic Frameworks  PD-L1 Aptamer  Spherical Nucleic Acids (SNAs)   In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 11 作者:  Hou, Bo;  Ye, Jiayi;  Li, Junhao;  Xu, Zhiai;  Yu, Haijun   |  收藏  |  浏览/下载：29/0  |  提交时间：2023/04/10 Immune-excluded tumor  Extracellular matrix  In-situ click reaction  Prodrug nanoparticles  Immune resistance   Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to boost antitumor immunity 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 10 作者:  Deng, Zheng;  Liu, Jiawei;  Xi, Min;  Wang, Chunjie;  Fang, Huapan   |  收藏  |  浏览/下载：3/0  |  提交时间：2023/12/29 Radiotherapy  Platinum nanoparticles  Shewanella oneidensis MR-1  Immune checkpoint blockade  Anti-tumor immunity